WCN24-1550 ALDOSTERONE SYNTHASE INHIBITION WITH OR WITHOUT BACKGROUND SODIUM GLUCOSE COTRANSPORTER 2 INHIBITION IN CKD: A PHASE II CLINICAL TRIAL
Saved in:
| Main Authors: | Katherine Tuttle, Sibylle Hauske, Shimoli V. Shah, Lisa Cronin, Zhichao Sun, Dick de Zeeuw, Hiddo J.L. Heerspink, Peter Rossing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924002559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD
by: Peter Rossing, et al.
Published: (2025-02-01) -
Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial
by: Frederik H. Mårup, et al.
Published: (2024-08-01) -
Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time?
by: Alessio Mazzieri, et al.
Published: (2024-01-01) -
How to measure and monitor albuminuria in healthy toddlers?
by: Sophie Marielle van den Belt, et al.
Published: (2018-01-01) -
Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review
by: Joey A. Mercier, MD, FRCPC, et al.
Published: (2025-04-01)